Targeting Alzheimer’s Disease Neuro-Metabolic Dysfunction with a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Disease Pathologies

BACKGROUND: Alzheimer’s disease (AD) could be regarded as a brain form of diabetes since insulin resistance and deficiency develop early and progress with severity of neurodegeneration. Preserving insulin’s actions in the brain restores function and reduces neurodegeneration. T3D-959 is a dual nucle...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Ming, Dominguez, Cesar, Didsbury, John, de la Monte, Suzanne M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979550/
https://www.ncbi.nlm.nih.gov/pubmed/27525190
http://dx.doi.org/10.4172/2161-0460.1000238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979550/
https://www.ncbi.nlm.nih.gov/pubmed/27525190
http://dx.doi.org/10.4172/2161-0460.1000238

Ejemplares similares